Literature DB >> 15095286

Expression and regulation of the insulin-like growth factor axis components in rat liver myofibroblasts.

Ruslan Novosyadlyy1, Kyrylo Tron, Jozsef Dudas, Giuliano Ramadori, Jens-Gerd Scharf.   

Abstract

UNLABELLED: Apart from hepatic stellate cells (HSC), liver myofibroblasts (MF) represent a second mesenchymal cell population involved in hepatic fibrogenesis. The IGF system including the insulin-like growth factors I and II (IGF-I, -II), their receptors (IGF-I receptor, IGF-IR; IGF-II/mannose 6-phosphate receptor, IGF-II/M6-PR), and six high affinity IGF binding proteins (IGFBPs) participate in the regulation of growth and differentiation of cells of the fibroblast lineage, possibly contributing to the fibrogenic process. The aim of this work was to study the expression and regulation of the IGF axis components in rat liver MF.
METHODS: Cultures of MF from passages 1 to 4 (P1-4) were studied. IGFBP secretion was analyzed by [(125)I]-IGF-I ligand and immunoblotting. IGF-I, IGF-IR, IGF-II/M6-PR, and IGFBP messenger RNA (mRNA) expression was assessed by Northern blot hybridization. DNA synthesis was evaluated by 5-bromo-2'-deoxyuridine (BrdU) incorporation assay.
RESULTS: MF from P1 to 4 constitutively expressed mRNA transcripts specific for IGF-I, IGF-IR, and IGF-II/M6-PR. In MF, biosynthesis of IGFBP-3 and -2 was observed that was stimulated by IGF-I, insulin, and transforming growth factor beta (TGF-beta), whereas platelet-derived growth factor (PDGF-BB) revealed inhibitory effects. IGF-I and to a lesser extent insulin increased DNA synthesis of MF. Simultaneous addition of recombinant human IGFBP-2 or -3 with IGF-I diminished the mitogenic effect of IGF-I on MF whereas preincubation of MF with IGFBP-2 or -3 further potentiated the IGF-I stimulated DNA synthesis. In conclusion, the present study demonstrates that the IGF axis may play a role in the regulation of MF proliferation in vitro which might be relevant in vivo for the process of fibrogenesis during acute and chronic liver injury. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095286     DOI: 10.1002/jcp.10437

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

Review 1.  Insulin-like growth factors in the gastrointestinal tract and liver.

Authors:  John F Kuemmerle
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-15       Impact factor: 4.741

2.  Tumor induced local fibrogenic effect by hepatic metastasis of insulinoma.

Authors:  Thomas Longerich; Knut Ketterer; Burkhard M Helmke; Helmut Friess; Peter Schirmacher
Journal:  Virchows Arch       Date:  2005-05-19       Impact factor: 4.064

3.  Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells.

Authors:  Rick Greupink; Hester I Bakker; Harry van Goor; Martin H de Borst; Leonie Beljaars; Klaas Poelstra
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

4.  Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury.

Authors:  Jozsef Dudas; Tümen Mansuroglu; Danko Batusic; Giuliano Ramadori
Journal:  Histochem Cell Biol       Date:  2008-09-17       Impact factor: 4.304

5.  Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line.

Authors:  Lori K Davis; Buel D Rodgers; Kevin M Kelley
Journal:  Endocrine       Date:  2008-04-08       Impact factor: 3.633

Review 6.  Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma.

Authors:  Maaged Akiel; Devaraja Rajasekaran; Rachel Gredler; Ayesha Siddiq; Jyoti Srivastava; Chadia Robertson; Nidhi Himanshu Jariwala; Paul B Fisher; Devanand Sarkar
Journal:  J Hepatocell Carcinoma       Date:  2014-03-26

7.  The type I insulin-like growth factor regulates the liver stromal response to metastatic colon carcinoma cells.

Authors:  Maria Celia Fernandez; Roni Rayes; Boram Ham; Ni Wang; France Bourdeau; Simon Milette; Martin Lllemann; Nigel Bird; Ali Majeed; Jun Xu; Tatiana Kisselova; Pnina Brodt
Journal:  Oncotarget       Date:  2016-10-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.